The immunohistochemical study confirmed the biphasic phenotype of the proliferation, by demonstrating the expression of general neuroendocrine markers and SSTR2A limited to LCNEC, which, in turn, was negative for hormonal receptors (estrogen and progesterone receptors). This evidence concerns the gene NR4A1 and large cell neuroendocrine carcinoma.